Untitled

Untitled

Benefits of treatment with SGLT2i and GLP-1RA based on their direct and indirect metabolic, cardiovascular, and renal effects. SGLT2i: Sodium-glucose cotransporter-2 inhibitors, GLP-1RA: Glucagon-like peptide-1 receptor agonists.

Benefits of treatment with SGLT2i and GLP-1RA based on their direct and indirect metabolic, cardiovascular, and renal effects. SGLT2i: Sodium-glucose cotransporter-2 inhibitors, GLP-1RA: Glucagon-like peptide-1 receptor agonists.

Be the first to comment

Leave a Reply

Your email address will not be published.


*